Abbott RealTime SARS-CoV-2 Assay

Abbott RealTime SARS-CoV-2 assay provides a fully automated solution to help laboratories address the urgent need for automated, high-volume patient testing during the Coronavirus (COVID-19) pandemic.

The assay is engineered with:

  • Dual target assay for RdRp and N-genes
  • Qualitative detection of nucleic acids from SARS-CoV-2
  • maxRatio data analysis removes operator subjectivity

The Abbott RealTime SARS-CoV-2 assay in combination with the RealTime m2000 system allow scalable, automated process for flexible testing volume (24-96 samples) and up to 470 patient samples in 24 hours.